Videos & Webinars - European Medical Journal

Continue

Video & Webinars

EMJ
Oncology
26 Jun 2015

Improved Cancer Treatments Linked to Reduced Late Mortality in Childhood Cancer Survivors

Data from the Childhood Cancer Survivor Study (CCSS), a retrospective cohort study of children diagnosed with cancer from 1970–1999 at 31 participating…
EMJ
Oncology
26 Jun 2015

Combined Nivolumab and Ipilimumab or Monotherapy Shown Promise in Untreated Melanoma

The randomised, double-blind, phase 3 CheckMate 067 trial showed that nivolumab alone or nivolumab plus ipilimumab significantly improved progression…
EMJ
Oncology
26 Jun 2015

Novel JAK Inhibitor Pacritinib Proves Effective for Easing Symptoms of Myelofibrosis

Findings from the PERSIST-1 study of patients with myelofibrosis suggest that pacritinib is significantly more effective than best available therapy…
EMJ
Oncology
26 Jun 2015

Obinutuzumab Doubles Remission Duration in Relapsed, Indolent Non-Hodgkin Lymphoma

Interim analysis of a phase III study finds that adding the new anti-CD20 monoclonal antibody obinutuzumab to standard bendamustine chemotherapy…
EMJ
Oncology
26 Jun 2015

Daratumumab Shows Promise in Heavily Treatment-Resistant Multiple Myeloma

A phase II trial suggests that anti-CD38 antibody daratumumab is effective as a standalone therapy for heavily treated multiple myeloma. In a group of…
EMJ
Oncology
26 Jun 2015

New Ibrutinib Combination Regimen Shows Substantial Benefits in Relapsed CLL

An interim analysis of a large phase III study suggests that the combination of ibrutinib and bendamustine/rituximab (BR) improves outcomes for patients…
Nephrology
25 Jun 2015

A. Erdem Canda: Trends and Developments in Endourology

Dr A. Erdem Canda Chairs a Discussion on the Trends and Developments in the Field of Endourology
EMJ
Urology
25 Jun 2015

Interview: Abolfazl Hosseni

An Interview with Dr. Abolfazl Hosseni at the 11th National Endourology Congress, Discussing the Developing Treatment in Bladder Cancer